Home / Ondansetron / Canada
CA ATC A04AA01 · updated 2 Nov 2026
Ondansetron shortage in Canada
Is there an Ondansetron shortage in Canada?
Yes. As of 2 Nov 2026, 14 Ondansetron products are reported short in Canada, the first since 29 Feb 2016. The company estimate for the return is 13 Nov 2026 (latest 8 Jan 2027). Main reason: manufacturing problem.
Also short in France, Italy, Spain, Ireland, Austria, Czechia, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ONDANSETRON INJECTION (20ML) | TEVA CANADA LIMITED | 29 Feb 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ONDANSETRON INJECTION (2ML) | TEVA CANADA LIMITED | 29 Feb 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-ONDANSETRON (10UD) | TEVA CANADA LIMITED | 7 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-ONDANSETRON (100) | TEVA CANADA LIMITED | 5 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-ONDANSETRON (100) | TEVA CANADA LIMITED | 5 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ONDANSETRON (50 ML) | APOTEX INC | 30 Dec 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP ONDANSETRON (50) | JAMP PHARMA CORPORATION | 31 May 2026 | 11 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP ONDANSETRON ODF (10) | JAMP PHARMA CORPORATION | 30 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP ONDANSETRON ODF (10) | JAMP PHARMA CORPORATION | 30 Jun 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ONDANSETRON (30 BTL) | APOTEX INC | 8 Sep 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ONDANSETRON (10 BLS) | APOTEX INC | 22 Sep 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ONDANSETRON (30 BTL) | APOTEX INC | 27 Oct 2026 | 8 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACCEL-ONDANSETRON ODT (10 TABLETS) | ACCEL PHARMA INC | 1 Nov 2026 | 15 Nov 2026 | Active ingredient shortage Shortage of an active ingredient |
| CA | ACCEL-ONDANSETRON ODT (10 TABLETS) | ACCEL PHARMA INC | 1 Nov 2026 | 15 Nov 2026 | Active ingredient shortage Shortage of an active ingredient |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.